ASCENTAGE PHARMA GR-ADR (AAPG) Stock Earnings & Estimates
USA - NASDAQ:AAPG - ADR
40.15 USD
+0.57 (+1.44%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 209.711M 651.38% | 221.984M 5.85% | 980.65M 341.77% | 598.12M -39.01% | 2.803B 368.64% | 1.845B -34.18% | 2.27B 23.04% | 2.952B 30.04% | 2.751B -6.81% | 3.244B 17.92% | 3.745B 15.44% | |
| EBITDA YoY % growth | -791.464M 8.49% | -796.726M -0.66% | -281.002M 64.73% | -978.571M -248.24% | 935.12M 195.56% | -477.615M -151.08% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -852.935M 4.51% | -874.038M -2.47% | -374.171M 57.19% | -1.047B -179.93% | 678.44M 164.77% | -208.155M -130.68% | 180.45M 186.69% | 661.87M 266.79% | 731.96M 10.59% | 1.264B 72.69% | 1.763B 39.48% | |
| Operating Margin | -406.72% | -393.74% | -38.16% | -175.12% | 24.20% | -11.28% | 7.95% | 22.42% | 26.61% | 38.96% | 47.08% | |
| EPS YoY % growth | N/A -6.38% | N/A 12.05% | N/A 61.78% | -11.54 -186.08% | 8.71 175.51% | -2.75 -131.55% | N/A | N/A | N/A | N/A | N/A |
All data in CNY
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in CNY
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 233.699M -71.63% | % | ||
| Q4 2024 Q2Q % growth | 156.904M 97.90% | % | ||
| Q2 2024 Q2Q % growth | 823.746M 477.25% | % | ||
| Q4 2023 Q2Q % growth | 79.283M -30.42% | % | ||
| Q2 2023 Q2Q % growth | 142.701M 49.01% | % | ||
| Q4 2022 Q2Q % growth | 113.948M 662.45% | % | ||
| Q2 2022 Q2Q % growth | 95.763M 638.63% | % | ||
| Q4 2021 Q2Q % growth | 14.945M 51.93% | % | ||
| Q2 2021 Q2Q % growth | 12.965M 396.17% | % | ||
| Q4 2020 Q2Q % growth | 9.837M -19.34% | % | ||
| Q2 2020 Q2Q % growth | 2.613M 12.78% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | -16.72% | -3.68% |
| Revenue | N/A | N/A | 5.66% | 12.86% |